Cell Culture
Cytovance’s core service is therapeutic protein and antibody production derived from mammalian cell culture. Production methods formalized during process development are executed under cGMP in our state-of-the-art facility. Cell culture is scaled up to our 500 L bioreactors for the bulk production phase. Multiple bioreactors may be used as necessary.
Capabilities include:
- Multiple suites available, dedicated or campaign basis
- 1 x 100L (w/v) and 1 x 500L (w/v) bioreactor suitable for batch, fed-batch or perfusion operations
- Roller bottle capabilities
- Clarification (filtration) and concentration (ultrafiltration/diafiltration) of unprocessed bulk
- CIP Skid, SIP bioreactors
- Media Prep area